Detection of vascular disease with labelled antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4877599
SERIAL NO

07220376

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Vascular diseases including asymptomatic atherosclerosis can be diagnosed by administering a conjugate diagnostic reagent to a patient and then detecting the location and concentration of the conjugate reagent within the patient's vascular system. The conjugate reagents have a target-seeking, biologically active molecule as one component and a labeling means capable of extracorporeal detection as the other component. The biologically active molecules (BAMs) are chosen to have affinity for structural elements of the arterial wall which are either not present in the normal wall but are found in atherosclerotic or arteritic lesions, or which are not available to the blood-borne reagent within normal arterial walls, but are exposed to the reagent in atherosclerotic or arteriotic lesions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NEW ENGLAND DEACONESS HOSPITAL CORPORATIONBOSTON MA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lees, Robert S Brookline, MA 23 291

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation